Novo Nordisk ® reasing with 700 million people 45 Of the 463 million, 32.8 million 1 people are currently treated with Novo Nordisk diabetes products 2.6 mio treated with GLP-1 3.0 mio treated with new-generation insulin 2.4 mio treate 1 d 3. w 1 it m h io treated with new-generatio m n o in d su e l r i n insulin 13.0 mio treated with modern insul 1 in 2.3 mio treated with human insulins 10.9 mio treated with human insulins 1 In addition to the above-mentioned product classes, oral anti-diabetics constitutes the remainder of people treated with Novo Nordisk products
Download PDF file